AWH 0.99 (-33.56%)
US04537Y1091Medical Diagnostics & ResearchDiagnostics & Research

Aspira Womens Health (AWH) Competitor Comparison

We are evaluating the key criteria listed to compare Aspira Womens Health (AWH) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - AWH ranking 18 / 58

These are the competitors of Aspira Womens Health in the industry Diagnostics & Research ranked by linearity 5 years
1. Qiagen QGEN
313.58
2. Inotiv NOTV
99.7
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Co-Diagnostics CODX
29.18
5. Syneos Health SYNH
24.79
6. DarioHealth DRIO
21.71
7. Heska HSKA
15.42
8. Myriad Genetics MYGN
13.36
9. Waters WAT
7.81
10. Trinity Biotech TRIB
7.02
11. IQVIA Holdings IQV
6.85
12. Anixa Biosciences ANIX
6.75
13. Quest Diagnostics DGX
6.74
14. Laboratory Corp of America Holdings LH
6.36
15. Charles River Laboratories CRL
6.3
16. NeoGenomics NEO
6.29
17. Pacific Biosciences of California PACB
6.04
18. Aspira Womens Health AWH
5.79
19. Fulgent Genetics FLGT
5.29
20. Neogen NEOG
5.1
21. Twist Bioscience TWST
5.05
22. PerkinElmer PKI
4.97
23. Olink Holding OLK
4.72
24. CareDx CDNA
3.95
25. National Research NRC
3.82
26. Agilent Technologies A
3.5
27. Sotera Health SHC
3.5
28. Guardant Health GH
3.49
29. Mettler-Toledo MTD
3.43
30. Exact Sciences EXAS
3.24
31. IDEXX Laboratories IDXX
3.17
32. Illumina ILMN
3.07
33. Thermo Fisher Scientific TMO
2.98
34. Enzo Biochem ENZ
2.89
35. Sera Prognostics SERA
2.62
36. Psychemedics PMD
2.58
37. Interpace Biosciences IDXG
2.45
38. Danaher DHR
2.44
39. Bioventus BVS
2.23
40. Global Cord Blood CO
2.23
41. Exagen XGN
2.2
42. MDxHealth MDXH
2.14
43. MaxCyte MXCT
2.13
44. Personalis PSNL
2.05
45. Neuronetics STIM
2.02
46. Biodesix BDSX
2
47. Precipio PRPO
1.98
48. Prenetics Global PRE
1.91
49. Icon ICLR
1.79
50. bioAffinity Technologies BIAF
1.68
51. Organovo Holdings ONVO
1.6
52. DexCom DXCM
1.53
53. SeqLL SQL
1.39
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.78
56. Lantheus Holdings LNTH
0.64
57. RadNet RDNT
0.38
58. Medpace Holdings MEDP
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.